Farms.com Home   News

Potato Harvest Wrapping Up

Manitoba's potato harvest is nearly complete.
 
Dan Sawatzky is manager of Keystone Potato Producers Association.
 
"Harvest conditions have been excellent this year," he said. "Many growers probably finished in record time. There's still a few potatoes left but I would say we're probably close to 95 per cent complete."
 
Sawatzky says yields are down a bit this year.
 
"Yields are off a little bit. We had a bit later start and some heat during when potatoes were setting. We lost some of the sets and then also later on, third week of August we had some heat as well and potatoes just don't do very well when it's too hot. They shut down and consequently we are a little bit down in yield."
 
He notes the quality of the potato crop is looking good, noting the size of the potatoes is better than expected. Sawatzky says most of the processing producers have irrigation, adding storability should also be good. The early September frost did impact some of the plants, and prevented some extra yield that might have occurred during that time.
 
There were no reported cases of late blight in Manitoba.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.